Share This Page
Drug Price Trends for HM DOCOSANOL
✉ Email this page to a colleague

Average Pharmacy Cost for HM DOCOSANOL
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
HM DOCOSANOL 10% CREAM | 62011-0433-01 | 6.15115 | GM | 2025-03-19 |
HM DOCOSANOL 10% CREAM | 62011-0433-01 | 6.02291 | GM | 2025-02-19 |
HM DOCOSANOL 10% CREAM | 62011-0433-01 | 5.91398 | GM | 2025-01-22 |
HM DOCOSANOL 10% CREAM | 62011-0433-01 | 6.02264 | GM | 2024-12-18 |
HM DOCOSANOL 10% CREAM | 62011-0433-01 | 5.97526 | GM | 2024-11-20 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for Docosanol
Introduction to Docosanol
Docosanol, marketed under the brand name Abreva, is a topical antiviral drug used to treat recurrent herpes simplex labialis (HSL), commonly known as cold sores or fever blisters. It is a saturated 22-carbon aliphatic alcohol that inhibits the fusion of the herpes simplex virus (HSV) with the human cell plasma membrane, preventing viral entry and replication[4].
Market Size and Growth Projections
The global docosanol cream market is anticipated to experience significant growth over the forecast period from 2024 to 2031. Here are some key points regarding the market size and growth projections:
- Market Expansion: The docosanol cream market has witnessed swift and substantial growth in recent years and is expected to continue this upward trajectory. The market is projected to expand at a remarkable Compound Annual Growth Rate (CAGR) during the forecast period[3].
- Segmentation: The market is categorized based on type (online and offline) and application (cold sores and fever blisters), with geographical regions including North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa[3].
Market Drivers
Several factors are driving the growth of the docosanol cream market:
- Increasing Prevalence of Herpes Simplex Labialis: Recurrent HSL affects 20% to 40% of the US population, creating a significant demand for effective treatments[1].
- Efficacy and Safety: Docosanol has been proven to be safe and effective in treating HSL, reducing healing time and alleviating symptoms such as pain, itching, and burning[1].
- Convenience and Accessibility: As an over-the-counter (OTC) medication, docosanol is easily accessible to consumers, contributing to its market growth[2].
Market Restraints
Despite the positive outlook, there are some restraints to consider:
- Limited Insurance Coverage: Since docosanol is an OTC medication, it is not covered by insurance plans, which might affect its adoption among some consumers[2].
- Competition from Other Antivirals: The market for cold sore treatments is competitive, with other antiviral medications available, which could impact docosanol's market share[4].
Price Analysis
The pricing of docosanol can vary based on several factors, including location and the use of discount cards:
- Retail Price: The average retail price of docosanol without insurance is around $26.26 for a 2gm tube of 10% cream[2].
- Discounts and Coupons: Using a SingleCare discount card can reduce the price to as low as $12.13 at participating pharmacies such as Target, Walmart, and Walgreens[2].
- Pharmacy Variations: Prices can vary significantly between different pharmacies, with prices ranging from $18.15 at Kroger Pharmacy to $30.52 at Walmart[2].
Price Projections
Given the anticipated market growth and increasing demand, here are some price projection insights:
- Stable Pricing: Despite market growth, the prices of docosanol are likely to remain relatively stable due to its status as an OTC medication and the availability of discounts and coupons[2].
- Potential for Slight Increases: As the market expands, there might be slight price increases, but these are expected to be minimal and influenced more by pharmacy pricing strategies than by overall market dynamics[3].
Consumer Behavior and Market Trends
Consumer behavior and market trends play a crucial role in shaping the docosanol market:
- Increased Health Awareness: Growing awareness about health and wellness is driving consumers to seek effective treatments for conditions like HSL, boosting demand for docosanol[3].
- Online Purchases: The rise in online shopping is expected to contribute to the growth of the docosanol market, especially in the online segment[3].
Key Takeaways
- Market Growth: The docosanol cream market is expected to grow significantly over the forecast period.
- Efficacy and Safety: Docosanol is proven to be safe and effective in treating HSL.
- Price Stability: Prices are likely to remain stable with potential for slight increases.
- Consumer Demand: Increasing health awareness and online shopping trends are driving market growth.
FAQs
Q: What is docosanol used for? A: Docosanol is used to treat recurrent herpes simplex labialis (HSL), commonly known as cold sores or fever blisters.
Q: How does docosanol work? A: Docosanol inhibits the fusion of the herpes simplex virus (HSV) with the human cell plasma membrane, preventing viral entry and replication[4].
Q: Is docosanol covered by insurance? A: No, docosanol is an over-the-counter medication and is not covered by insurance plans[2].
Q: How much does docosanol typically cost? A: The average retail price of docosanol is around $26.26, but it can be reduced to as low as $12.13 with a SingleCare discount card[2].
Q: What are the common side effects of docosanol? A: Adverse experiences with docosanol are generally mild and similar to those with placebo, including minor skin irritation[1].
Sources
- Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis - PubMed
- Docosanol Coupons & Prices - SingleCare
- Global Docosanol Cream Market Size, Trends and Projections - Market Research Intellect
- Docosanol: Uses, Interactions, Mechanism of Action - DrugBank
More… ↓